Article Information
vol. 4 no. 153 153ps18
- .
Author Information
- Kathleen M. Giacomini1,*,
- Sook Wah Yee1,
- Mark J. Ratain2,
- Richard M. Weinshilboum3,
- Naoyuki Kamatani4 and
- Yusuke Nakamura5
- 1Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94143, USA.
- 2Department of Medicine, Comprehensive Cancer Center, and Committee on Clinical Pharmacology and Pharmacogenomics, University of Chicago, Chicago, IL 60637, USA.
- 3Department of Molecular Pharmacology and Experimental Therapeutics, Division of Clinical Pharmacology, Mayo Clinic, Rochester, MN 55905, USA.
- 4Laboratory for Statistical Analysis, Center of Genomic Medicine, Institute of Physical and Chemical Research (CGM, RIKEN), Tokyo, Japan.
- 5Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
- ↵*Corresponding author. E-mail: kathy.giacomini{at}ucsf.edu